Small cell lung cancer extensive stage
Not recruitingStudy of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer
Study of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer
- Disease:Small cell lung cancer extensive stage
- Substances:AtigotatugCarboplatin+2
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Atigotatug
- Sponsor:Bristol Myers Squibb International Corporation









